NEWS
Lung Cancer Compact Panel, a Highly Sensitive Multiplex Companion Diagnostic, has been submitted for PMDA approval.
October 28, 2021
On October 21, 2021, DNA Chip Research Inc. (Ryo Matoba, the president) announced that they have developed a multi-CDx system, a high-sensitivity genetic test to detect abnormal (mutated) DNA in FFPE tissue/Cytology specimens, for targeted therapies of lung cancer. The program, “Lung Cancer Compact Panel Dx Multiplex Companion Diagnostics Test” has been submitted for approval to the concerned Japanese authorities.